WASHINGTON, DC, Nov 10 (MARKET WIRE) --
England & Company, a Washington, DC-based merchant bank, announced today
the appointment of Dennis Weissman as a Senior Advisor to the firm.
Mr. Weissman, the founder and Executive Editor of the Washington G-2
Reports, is one of the nation's leading experts in the clinical diagnostic
laboratory and pathology sectors. At England & Company, he will provide
strategic advice as the firm expands its activity in the health care
industry. Recently, England & Company has completed several transactions
in the laboratory industry, including the recapitalizations of Pathology,
Inc. and DCL Medical Laboratories, and the acquisition of DrugScan, Inc.
and DSI Medical Laboratories.
"I am pleased to join the team at England & Company. Their reputation,
integrity and passion for excellence, combined with their commitment to
the health care industry, provide a truly exciting platform to serve the
industry," said Mr. Weissman.
Craig England, CEO of England & Company, said, "We are pleased to have
someone with Dennis' unique experience join our health care practice as a
Senior Advisor. My partners and I look forward to leveraging his public
policy expertise and his vast knowledge of the lab industry in this period
of significant change and opportunity in the health care markets."
"I look forward to continuing to work with Dennis to build on our recent
successes in the lab industry," added Tim Johnson, Managing Director and
lead health care banker at England & Company. "With the addition of Dennis
to our firm, we now offer an unparalleled combination of transactional
experience, policy insights and relationships in the laboratory industry."
About Dennis Weissman
Dennis Weissman is one of the nation's leading experts in the clinical
diagnostic laboratory and pathology sectors. Mr. Weissman was the founder
of the Washington G-2 Reports, a leading national news and information
company serving the clinical diagnostic industry, and he continues to
serve as the company's Executive Editor.
Prior to forming the Washington G-2 Reports, Mr. Weissman headed the
Washington Office for the American Society for Medical Technology (now
ASCLS) and prior to that served as Special Assistant to the Deputy
Assistant Secretary for Health in the Department of Health, Education &
Welfare. After completing a tour of duty with the U.S. Army at the
Pentagon where he worked in White House and congressional liaison, Mr.
Weissman began his first civilian position in the nation's capital as a
government affairs executive with the American Optometric Association.
In addition to his work with England & Company, Mr. Weissman serves as
President of Dennis Weissman & Associates, LLC, a consulting firm that
provides strategic market intelligence, organizational support, and public
policy and trends assessments, for laboratory organizations and related
interests.
Mr. Weissman received his BA in Political Science from the State
University of New York at Buffalo and his MS degree in Counseling and
Higher Education Administration from Indiana University at Bloomington.
He serves on the Board of Directors of the National Cervical Cancer
Coalition and is a member of the Health Advisory Committee, School of
Business Administration at Marymount University.
About England & Company
England & Company (www.englandco.com) is a Washington, DC-based merchant
bank focused on providing the highest quality investment banking services
and value-added capital to middle market companies and their financial
sponsors. The firm's principals bring extensive investment banking and
private equity experience to companies in the following industries:
-- Energy & Infrastructure Technology
-- Financial Services
-- Healthcare
-- Software & IT Services
England Securities, a wholly owned subsidiary of England & Company and
member of FINRA and the SIPC, advises clients on strategic initiatives,
including mergers, acquisitions, financial restructurings, and capital
formation.
England Capital Partners combines the experience and relationships of the
firm's principals and advisors to identify private investment
opportunities and partner with strong management teams in England &
Company's focus industries.
Contact:
Craig England
(202) 386-6500
Copyright 2009, Market Wire, All rights reserved.
-0-
